In this analysis, the semi-mechanistic exposure-response model we developed successfully established quantitative links among dapagliflozin exposure, the basal daily insulin dose, plasma glucose concentrations, and HbA1c levels in patients with T1D. The gene discussed is INS; the disease is type 1 diabetes mellitus.